Epigenetic Impact of Stem Cell Toxicants
- 9 August 2016
- book chapter
- Published by Royal Society of Chemistry (RSC)
- p. 178-195
Abstract
Human embryonic stem cells (ESCs) virtually represent the simulation source of a wide range of modern tissue specific toxicity models with an ability to replace the conventional animal models. Dynamic landscapes of epigenetic alterations play an essential role in regulation of multi-lineage differentiation capabilities and other relevant attributes of ESCs. Exogenous agents that are able to interfere with such programming may act as developmental toxicants. These stem cell toxicants have been reported to either induce or respond to complex biological signaling cascades including epigenetic perturbations. Herein, we propose that chemical toxicant-induced epigenetic changes of stem cells in the form of promoter DNA/histone methylation at a few repressed genes could poise their cellular phenotype. This may cause either abnormal expansion of their number or inhibition of their differentiation ability. In this chapter, we will discuss the biochemical characteristics and epigenetic effects of various stem cell toxicants. We will also cover the possibilities for incorporation of epigenetic assays in stem cell toxicological studies.Keywords
This publication has 96 references indexed in Scilit:
- Epigenetic Changes in Individuals with ArsenicosisChemical Research in Toxicology, 2011
- Systems biology of stem cell fate and cellular reprogrammingNature Reviews Molecular Cell Biology, 2009
- Modulation of histone methylation and MLH1 gene silencing by hexavalent chromiumToxicology and Applied Pharmacology, 2009
- Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmiumMetallomics, 2009
- Effects of nickel, chromate, and arsenite on histone 3 lysine methylationToxicology and Applied Pharmacology, 2009
- Iron- and 2-oxoglutarate-dependent Dioxygenases: an emerging group of molecular targets for nickel toxicity and carcinogenicityBioMetals, 2008
- Nickel compounds induce histone ubiquitination by inhibiting histone deubiquitinating enzyme activityToxicology and Applied Pharmacology, 2008
- Genetic and Epigenetic Mechanisms in Metal Carcinogenesis and Cocarcinogenesis: Nickel, Arsenic, and ChromiumChemical Research in Toxicology, 2007
- Epigenetic reprogramming and imprinting in origins of diseaseReviews in Endocrine and Metabolic Disorders, 2007
- Transposable elements and the epigenetic regulation of the genomeNature Reviews Genetics, 2007